Dapagliflozin
Cat.No:ID1220 Solarbio
CAS:461432-26-8
Molecular Formula:C21H25ClO6
Molecular Weight:408.87
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥97%
Appearance:White to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart> Small Molecule Compounds > Inhibitors & Antagonists & Agonists > Membrane Transporter & Ion Channel > DapagliflozinCAS:461432-26-8
Molecular Formula:C21H25ClO6
Molecular Weight:408.87
Storage:Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥97%
Appearance:White to yellow Solid
Qty:
Size:
| CAS | 461432-26-8 |
| Name | Dapagliflozin |
| Molecular Formula | C21H25ClO6 |
| Molecular Weight | 408.87 |
| Solubility | Soluble in DMSO ≥10mg/mL;Soluble in Ethanol ≥25mg/mL |
| Purity | HPLC≥97% |
| Appearance | White to yellow Solid |
| Storage | Powder:-20℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
| EC | EINECS 639-683-0 |
| MDL | MFCD13182359 |
| SMILES | O[C@H]1[C@H](C2=CC(CC3=CC=C(OCC)C=C3)=C(Cl)C=C2)O[C@H](CO)[C@@H](O)[C@@H]1O |
| Target Point | SGLT |
| Passage | Membrane Transporter&Ion Channel |
| Background | Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor. |
| Data Literature Source | [1]. Pedersen MG,et al. Dapagliflozin stimulates glucagon secretion at high glucose: experiments and mathematical simulations of human A-cells. Sci Rep. 2016 Aug 18;6:31214. [2]. Yoon-Kyung Chang,et al. Dapagliflozin,SGLT2 Inhibitor,Attenuates Renal Ischemia-Reperfusion Injury. PLoS One. 2016; 11(7): e0158810. [3]. Chiba Y,et al. Dapagliflozin,a Sodium-Glucose Co-Transporter 2 Inhibitor,Acutely Reduces Energy Expenditure in BAT via Neural Signals in Mice. PLoS One. 2016 Mar 10;11(3):e0150756. [4]. Akahane K,et al. Efficacy of Mitiglinide Combined with Dapagliflozin in Streptozotocin-nicotinamide-induced Type 2 Diabetic Rats and in Zucker Fatty Rats. Drug Res (Stuttg). 2015 Aug;65(8):416-21. [5]. Sakaeda T,et al. Susceptibility to serious skin and subcutaneous tissue disorders and skin tissue distribution of sodium-dependent glucose co-transporter type 2 (SGLT2) inhibitors. Int J Med Sci. 2018 Jun 13;15(9):937-943. |
| Unit | Bottle |
| Specification | 10mg 10mM*1mL in DMSO 50mg 100mg |
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.
Manual Download